Gene Expression Profile of Intestinal Organoids from People with Cystic Fibrosis upon Exposure to Elexacaftor/Tezacaftor/Ivacaftor

Scientists characterized the effect of elexacaftor/tezacaftor/ivacaftor (ETI) on the transcriptional activity of patient-derived intestinal organoids-derived cells to understand the intracellular processes triggered by ETI and the differences in treatment response.